Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,028
-$596,676 QoQ
Shares Held
338
-90.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#809
of 1,028 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Mar 31, 2020CallValue
$7,000
CallShares
160
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $668,956,159 across 9 Drug Manufacturers - General names. BIIB ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
851,550 | $308,363,285 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,158,772 | $272,739,254 | |
| 3 | LLY |
ELI LILLY & Co
|
29,882 | $35,841,370 | |
| 4 | JNJ |
Johnson & Johnson
|
103,280 | $26,230,021 | |
| 5 | MRK |
Merck & Co., Inc.
|
113,061 | $14,528,338 | |
| 6 | ABBV |
AbbVie Inc.
|
40,476 | $10,185,380 | |
| 7 | PFE |
Pfizer Inc
|
38,431 | $925,418 | |
| 8 | BIIB |
Biogen Inc.
This page
|
338 | $73,028 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,028 | 338 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $669,704 | 3,653 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $627,404 | 3,565 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $590,157 | 4,213 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $50,487 | 402 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,009 | 402 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $405,543 | 2,652 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $510,574 | 2,634 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,368,201 | 5,902 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,295,505 | 6,008 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,195,663 | 8,485 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,449,871 | 17,314 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,291,590 | 25,598 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,868,453 | 24,704 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,865,635 | 28,404 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,672,245 | 28,735 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,456,089 | 21,850 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,706,910 | 22,350 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $125,958,000 | 525,000 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $149,135,730 | 527,000 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $182,865,187 | 528,100 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $156,212,400 | 558,400 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $138,101,040 | 564,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,439,648 | 8,600 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $2,689,230 | 8,500 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $7,000 | 160 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||